JPRN-jRCT1080223950已完成Unknown
Prospective, Post Marketing Surveillance of GOOFICE 5mg Tablet
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with chronic constipation
排除标准
- •Off-label set
研究者
相似试验
已完成
Unknown
Prospective, Post Marketing Surveillance of MOVICOPatients with chronic constipationJPRN-jRCT1080224644EA Pharma Co., Ltd.900
招募中
不适用
Prospective, Post Marketing Surveillance of CAROGRA Tabletslcerative colitisD003093JPRN-jRCT2031220193Arai Yuki300
尚未招募
4 期
Study to evaluate safety of FDC of Evogliptin 5mg and Metformin hydrochloride IP (SR) 1000 mg film coated bilayered tablet available in marketCTRI/2020/08/027111Alkem Laboratories Limited
进行中（未招募）
不适用
reactogenicity and safety of Vaxem™HibMeningitis, epiglottitis, pneumonia, arthritis caused by Haemophilus influenzae type b.EUCTR2014-005203-24-Outside-EU/EEAovartis Vaccines and Diagnostics750
尚未招募
4 期
A post-marketing surveillance for the Evaluation of the safety of TGlobulin25 for the induction of immunosuppressive therapy in adult kidney transplant candidatesIRCT20201230049888N1Kawsar biotech company100